Neoadjuvant Chemotherapy Breast adenocarcinoma | Adjuvant Chemotherapy Breast adenocarcinoma
Item
breast adenocarcinoma treated by neoadjuvant or adjuvant chemotherapy within 12 months prior to study enrollment
boolean
C0600558 (UMLS CUI [1,1])
C3665472 (UMLS CUI [1,2])
C0858252 (UMLS CUI [1,3])
C0085533 (UMLS CUI [2,1])
C0858252 (UMLS CUI [2,2])
WHO performance status scale
Item
who performance status 0-1
boolean
C1298650 (UMLS CUI [1])
Age
Item
age ≥18 years old
boolean
C0001779 (UMLS CUI [1])
Affiliation Social Security Program | Beneficiary Social Protection Equivalent
Item
affiliation to a social security regime or beneficiary of equivalent social protection
boolean
C1510825 (UMLS CUI [1,1])
C0037435 (UMLS CUI [1,2])
C1550502 (UMLS CUI [2,1])
C0242457 (UMLS CUI [2,2])
C0205163 (UMLS CUI [2,3])
Informed Consent
Item
written informed consent provided before any study specific procedures
boolean
C0021430 (UMLS CUI [1])
Randomization
Item
complementary inclusion criterion for randomization
boolean
C0034656 (UMLS CUI [1])
Vitamin D Deficiency | Serum vitamin D measurement
Item
proved vitamin d deficiency as defined by serum vitamin d level lower than 30 ng/ml (75 nmol/l).
boolean
C0042870 (UMLS CUI [1])
C0428586 (UMLS CUI [2])
Neoplasm Metastasis
Item
metastatic disease
boolean
C0027627 (UMLS CUI [1])
Cancer Other | Exception Curative treatment Skin carcinoma | Exception Curative treatment Carcinoma in situ of uterine cervix
Item
history or presence of any other malignancy (except curatively treated nonmelanoma skin cancer or in situ cervix carcinoma) ………….
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C1273390 (UMLS CUI [2,2])
C0699893 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C1273390 (UMLS CUI [3,2])
C0851140 (UMLS CUI [3,3])
Patient Treated
Item
traités dans les 5 ans précédents.
boolean
C0030705 (UMLS CUI [1,1])
C1522326 (UMLS CUI [1,2])
Medical contraindication Calcium | Medical contraindication Cholecalciferol
Item
contraindication to calcium or cholecalciferol
boolean
C1301624 (UMLS CUI [1,1])
C0006675 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0008318 (UMLS CUI [2,2])
Severe allergy Vitamin D | Severe allergy Calcium supplementation | Severe allergy Vitamin D Excipient | Severe allergy Calcium supplementation Excipient
Item
known severe hypersensitivity to vitamin d or to calcium supplementation or to one of the excipients.
boolean
C2945656 (UMLS CUI [1,1])
C0042866 (UMLS CUI [1,2])
C2945656 (UMLS CUI [2,1])
C1096745 (UMLS CUI [2,2])
C2945656 (UMLS CUI [3,1])
C0042866 (UMLS CUI [3,2])
C0015237 (UMLS CUI [3,3])
C2945656 (UMLS CUI [4,1])
C1096745 (UMLS CUI [4,2])
C0015237 (UMLS CUI [4,3])
Disease Associated with Hypercalcemia | Medical condition Associated with Hypercalcemia | Disease Associated with Hypercalciuria | Medical condition Associated with Hypercalciuria
Item
disease and/or medical conditions accompanied by hypercalcaemia and/or hypercalciuria
boolean
C0012634 (UMLS CUI [1,1])
C0332281 (UMLS CUI [1,2])
C0020437 (UMLS CUI [1,3])
C3843040 (UMLS CUI [2,1])
C0332281 (UMLS CUI [2,2])
C0020437 (UMLS CUI [2,3])
C0012634 (UMLS CUI [3,1])
C0332281 (UMLS CUI [3,2])
C0020438 (UMLS CUI [3,3])
C3843040 (UMLS CUI [4,1])
C0332281 (UMLS CUI [4,2])
C0020438 (UMLS CUI [4,3])
Calcium Lithiasis | Calcinosis
Item
calcium lithiasis and tissue calcification
boolean
C0006675 (UMLS CUI [1,1])
C0023869 (UMLS CUI [1,2])
C0006663 (UMLS CUI [2])
Hypervitaminosis D
Item
hypervitaminosis d
boolean
C1442839 (UMLS CUI [1])
Comorbidity Significant
Item
presence of significant comorbidities:
boolean
C0009488 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
Endocrine System Disease Uncontrolled | Phosphorus and calcium disorders Laboratory testing | Osteopenia Requirement Vitamin D supplement | Osteoporosis Requirement Vitamin D supplement | Osteopenia Requirement Calcium supplements | Osteoporosis Requirement Calcium supplements
Item
i) uncontrolled endocrine disease ii) known disorders of calcium phophorus laboratory testing iii) proved osteopenia or osteoporosis requiring vitamin d and calcium supplements
boolean
C0014130 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0564731 (UMLS CUI [2,1])
C0022885 (UMLS CUI [2,2])
C0029453 (UMLS CUI [3,1])
C1514873 (UMLS CUI [3,2])
C3541352 (UMLS CUI [3,3])
C0029456 (UMLS CUI [4,1])
C1514873 (UMLS CUI [4,2])
C3541352 (UMLS CUI [4,3])
C0029453 (UMLS CUI [5,1])
C1514873 (UMLS CUI [5,2])
C3540037 (UMLS CUI [5,3])
C0029456 (UMLS CUI [6,1])
C1514873 (UMLS CUI [6,2])
C3540037 (UMLS CUI [6,3])
Investigational New Drugs | Calcium + vitamin D
Item
concomitant treatment with other experimental products or another vitamin d calcium treatment
boolean
C0013230 (UMLS CUI [1])
C0719107 (UMLS CUI [2])
Pregnancy | Breast Feeding | Childbearing Potential Contraceptive methods Absent
Item
pregnancy, breastfeeding or of reproductive potential not using an effective contraceptive method
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
Legal capacity Lacking | Legal capacity Restricted | Medical condition Preventing Completion of clinical trial | Mental condition Preventing Completion of clinical trial | Medical condition Preventing Informed Consent | Mental condition Preventing Informed Consent
Item
legal inability or restricted legal ability. medical or psychological conditions not allowing proper study completion or informed consent signature
boolean
C0683673 (UMLS CUI [1,1])
C0332268 (UMLS CUI [1,2])
C0683673 (UMLS CUI [2,1])
C0443288 (UMLS CUI [2,2])
C3843040 (UMLS CUI [3,1])
C1292733 (UMLS CUI [3,2])
C2732579 (UMLS CUI [3,3])
C3840291 (UMLS CUI [4,1])
C1292733 (UMLS CUI [4,2])
C2732579 (UMLS CUI [4,3])
C3843040 (UMLS CUI [5,1])
C1292733 (UMLS CUI [5,2])
C0021430 (UMLS CUI [5,3])
C3840291 (UMLS CUI [6,1])
C1292733 (UMLS CUI [6,2])
C0021430 (UMLS CUI [6,3])